When Will Johnson & Johnson Post a Profit from its COVID Vaccine?

Johnson & Johnson (NYSE:JNJ) is selling its vaccine without taking a profit during the pandemic. In this Motley Fool Live video recorded on Feb. 26, 2021, healthcare and cannabis bureau chief Corinne Cardina and Fool.com contributor Adria Cimino talk about the potential duration of the pandemic and what that means for Johnson & Johnson. Corinne Cardina: Another thing that is obviously important for investors to know is that Johnson & Johnson, like AstraZeneca, has already agreed not to profit during the pandemic from this vaccine. It might be more long term when we have to think of real profit for these companies. But I think in the long term it could be interesting because if it is every couple of years.